SOPAX
Price
$31.20
Change
+$0.01 (+0.03%)
Updated
Jul 13 closing price
Net Assets
9.42B
VSMPX
Price
$337.67
Change
-$2.70 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

SOPAX vs VSMPX

SOPAX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
SOPAX vs. VSMPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOPAX is a StrongBuy and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.3T vs. SOPAX (9.42B). SOPAX (1.08) and VSMPX (1.06) have matching dividends . SOPAX was incepted earlier than VSMPX: SOPAX (34 years) vs VSMPX (11 years). SOPAX (1.00) is less costly to investors than VSMPX (0.02). SOPAX is a more actively managed with annual turnover of: 30.00 vs. VSMPX (3.00). SOPAX has a lower initial minimum investment than VSMPX: SOPAX (1000) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 21.48 vs. SOPAX (3.78). VSMPX return over 5 years is better than : 66.52 vs. SOPAX (8.15).
SOPAXVSMPXSOPAX / VSMPX
Total Expense Ratio1.000.025,000%
Annual Report Gross Expense Ratio1.000.025,000%
Fund Existence34 years11 years-
Gain YTD7.49311.20667%
Front Load6%N/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets9.42B2.3T0%
Annual Yield % from dividends1.081.06101%
Returns for 1 year3.7821.4818%
Returns for 3 years14.3067.0321%
Returns for 5 years8.1566.5212%
Returns for 10 years64.02239.4327%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGSNX21.35N/A
N/A
Vanguard Real Estate Index Institutional
PCAOX91.03N/A
N/A
Principal Capital Appreciation R3
GARIX23.88N/A
N/A
Gotham Absolute Return Institutional
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C